Quantum-Si Incorporated (Nasdaq: QSI) is a life sciences technology company focused on semiconductor-based protein sequencing that went public through a business combination with HighCape Capital Acquisition Corp., a blank-check vehicle sponsored by HighCape Capital. The SPAC completed its IPO in 2020 and closed its de-SPAC merger with Quantum-Si in June 2021, bringing the company onto the Nasdaq exchange. The 10-Q/A filed on June 10, 2021 represents an amended quarterly disclosure submitted in connection with that transaction period. Quantum-Si operates in the genomics and life sciences instrumentation sector, developing proprietary chip technology for next-generation protein sequencing applications. Sign up at SpacDesk for full filings, timeline data, and analytics on QSI and hundreds of other SPAC transactions.